Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

AT&T: Should Investors Buy Into the Turnaround?


U.S. wireless company AT (NYSE: T) tarnished its reputation with ill-fated and expensive acquisitions beginning in 2014 that haunted the stock for roughly a decade.

Eventually, AT had to face the music. To its credit, AT made difficult decisions, including selling its media assets and slashing its dividend, to help pay down a massive debt load.

Today, AT&T stock is in a much better place. But is it time yet to fully buy into AT's turnaround?

Continue reading


Source Fool.com

Allergy Therapeutics PLC Stock

?
-3.640%
Heavy losses for Allergy Therapeutics PLC today as the stock fell by -€0.004 (-3.640%).

Like: 0
T
Share

Comments